EDITAS MEDICINE, INC. Marketable Securities (Non-Current)
EDITAS MEDICINE, INC. (EDIT) had Marketable Securities (Non-Current) of $0 as of 2024-12-31, per its 10-K filed 2025-03-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:MarketableSecuritiesNoncurrent · last filed 2025-03-05
- 2024-12-31: Marketable Securities, Noncurrent $0.00.
- 2024-09-30: Marketable Securities, Noncurrent $0.00.
- 2024-06-30: Marketable Securities, Noncurrent $39.20M.
- 2024-03-31: Marketable Securities, Noncurrent $80.61M.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-05 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-04 |
| 2024-06-30 | $39.20M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $80.61M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $104.02M 10-K · filed 2025-03-05 |
| 2023-09-30 | $96.80M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $48.06M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $83.34M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $93.10M 10-K · filed 2024-02-28 |
| 2022-09-30 | $58.84M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $75.06M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $78.05M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $120.07M 10-K · filed 2023-02-22 |
| 2021-09-30 | $99.20M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $87.58M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $97.89M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $109.66M 10-K · filed 2022-02-24 |
| 2020-09-30 | $45.99M 10-Q · filed 2020-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |